Clinical Trials Directory

Trials / Completed

CompletedNCT05262725

Behavioral Activation for Opioid Use Disorder

A Pilot Study of Behavioral Activation for People With Opioid Use Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall purpose of this pilot study is to evaluate the feasibility and acceptability of values-based behavioral activation (BA) as an adjunct intervention for patients receiving medications for opioid use disorder (OUD) in primary care. Researcher will evaluate the following aims: 1) examine the feasibility of BA for OUD in primary care, 2) examine whether the BA intervention and study requirements are acceptable to participants, and 3) determine the psychometric properties of the outcome measures in people with OUD. Participants will complete 4-6 brief counseling sessions over the course of 12 weeks. During the first session, participants will discuss values and recovery outcomes important to them. Next, they will set 2-3 personal goals to work on before the next BA session. At the follow-up sessions, participants will update the counselor on progress made or challenges experienced. Personal values will be reviewed and participant goals updated. Study measures (surveys and urine drug tests) will be completed at the start, partway through, and at the end of the intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALValues-based Behavioral ActivationInitially, patients complete a values assessment in which they identify personal values in various life domains. With the assistance of a clinician, patients set incremental behavior goals to move their daily actions to better align with their self-reported values. Goal completion allows the patient to achieve outcomes consistent with recovery, and they potentially experience enjoyment, self-efficacy, and confidence as they progress through the treatment.

Timeline

Start date
2022-03-30
Primary completion
2023-02-23
Completion
2023-02-23
First posted
2022-03-02
Last updated
2023-03-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05262725. Inclusion in this directory is not an endorsement.